Joint Ventures: EULAR 2026 Congress Preview
About this episode
Hosts preview the upcoming EULAR 2026 Congress, discussing key sessions and themes in rheumatology.
In this episode of Joint Ventures , hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MD, a consultant rheumatologist at Freeman Hospital, Newcastle, preview their unofficial countdown of the sessions, themes, and abstracts they are most excited about heading into the 2026 European Alliance of Associations for Rheumatology (EULAR) Annual Meeting in London, June 3–6, including: Obesity, Weight Management, and Psoriatic Arthritis Sessions Personalized Medicine and Biomarkers in RMDs Sessions Fatigue and Quality of Life in Connective Tissue Disease Session Mitochondrial DNA and Interferon: Upstream Drivers of Autoimmunity Session Artificial Intelligence and Pattern Recognition in Rheumatology Sessions Axial Imaging in Axial Spondyloarthritis Session Head-to-Head Superiority Trials in RA and PsA Sessions CAR-T and CAR-NK Therapies: Efficacy, Limits, and What Comes Next Sessions
People in this episode
Hosts: Jack Arnold, MBBS, PhD, Rihards Buss, MD
Topics covered
- Rheumatology
- EULAR Congress Preview
- Personalized Medicine
- Autoimmunity
- Artificial Intelligence in Medicine
- Quality of Life in Disease
Mentioned in this episode
Places: London
More episodes of HCPLive Podcasts
- Joint Ventures: The B-Cell Story, Part 2 — Ianalumab and the Next Chapter in Sjögren's and Lupus
- Joint Ventures: The B-Cell Story, Part 1 — From Rituximab to the Next Frontier
- Joint Ventures: GLP-1 Receptor Agonists — From Metabolic Drug to Immunomodulator? Part 2
- Joint Ventures: GLP-1 Receptor Agonists — From Metabolic Drug to Immunomodulator? Part 1
- Joint Ventures: Nipocalimab Advances and a Deucravacitinib Decision Looms
- Introducing Joint Ventures, With Jack Arnold, MBBS, PhD, and Rihards Buss, MBBS
Explore listener stats, chart rankings, contacts and more on the HCPLive Podcasts podcast page.